Showing results (1-10 of 579) with videos related to
Sort By:
Pageof 58
Cancer Biology & Therapy|January 11, 2005
Immunomodulation of multiple myelomaTanyifor M Tohnya, William D FiggCancer Biology & Therapy|August 27, 2005
Cyclooxygenase-2 and angiogenesis in prostate cancerVictoria L Tkacz, Tanyifor M Tohnya, William D FiggJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Determination of SU5416, a novel angiogenesis inhibitor, in human plasma by liquid chromatographyTanyifor M Tohnya, Sonia Kim, Howard A Fine, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 4, 2004
Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometryTanyifor M Tohnya, Kyunghwa Hwang, Erin R Lepper, et al.Journal of Clinical Pharmacology|May 20, 2009
Phase I study of oral lenalidomide in patients with refractory metastatic cancerWilliam L Dahut, Jeanny B Aragon-Ching, Sukyung Woo, et al.Cancer Biology & Therapy|November 26, 2010
Cabazitaxel: filling one of the gaps in the treatment of prostate cancerWilliam D Figg, William D FiggCancer Biology & Therapy|August 16, 2012
How do you want your steak prepared? The impact of meat consumption and preparation on prostate cancerWilliam D FiggCancer Biology & Therapy|September 21, 2007
Androgen receptor modulation: lessons learned from beyond the prostateNima Sharifi, William D FiggCancer Biology & Therapy|February 2, 2016
Resisting resistance: Establishing new treatment options for CRPC patientsShaunna Beedie, William D FiggCancer Biology & Therapy|May 12, 2004
Histone deacetylase inhibitors are potent radiation protectantsLuca Paoluzzi, William D FiggPageof 58